PERSEUS-PS Randomized Controlled Trial
NCT04428060 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14
Last updated 2023-10-02
Summary
The PERSEUS protocol is a new approach to the resuscitation of highly monitored patients with cardiac arrest. It aims at the optimization of all the available physiological parameters and the full exploitation of both the "cardiac pump" and "thoracic pump'. This protocol will help to titrate chest compressions, ventilation, and vasopressor dosing to physiological parameters, increasing survival after cardiac arrest with favorable neurological outcome
Conditions
- Cardiac Arrest
- Cardiopulmonary Arrest With Successful Resuscitation
Interventions
- OTHER
-
PERSEUS CPR
Resuscitation based on patient physiology
- OTHER
-
Standard CPR
Resuscitation based on current guidelines
Sponsors & Collaborators
-
University of Thessaly
lead OTHER
Principal Investigators
-
Athanasios Chalkias, MD, PhD · University of Thessaly
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-06-12
- Primary Completion
- 2022-12-30
- Completion
- 2022-12-30
Countries
- Greece
Study Locations
More Related Trials
-
Priming of Cardiopulmonary Bypass With Hydroxyethyl Starch 130/0.4 or Sodium Chloride 0.9% : Pilot Study in Adult Elective Conventional Cardiac Surgery
NCT02906514 ·Status: COMPLETED ·Phase: PHASE3
-
AMCPR (Augmented-Medication CardioPulmonary Resuscitation) Trial for OHCA
NCT03191240 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect Of Resuscitation Guided By Two Different Dynamic Parameters On Time To Normalization Of The Capillary Refill Time In Adult Patients With Septic Shock
NCT06122909 ·Status: COMPLETED ·Phase: PHASE3
-
Plasmalyte Versus Saline in Trauma Patients
NCT03630224 ·Status: TERMINATED ·Phase: PHASE3
-
Crystalloid Versus Hydroxyethyl Starch Trials
NCT00935168 ·Status: COMPLETED ·Phase: PHASE3
-
LUCAS Chest Compressor Versus Manual Chest Compression in Out-of-hospital Sudden Cardiac Arrest. LUCAT Trial
NCT01521208 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy of 5% Albumin v/s Plasmalyte in Combination With 20% Albumin for Fluid Resuscitation in Cirrhosis With Sepsis Induced Hypotension
NCT06076330 ·Status: UNKNOWN ·Phase: NA
-
Extension of the RUSH Protocol for Volume Responsiveness
NCT03285269 ·Status: WITHDRAWN
-
Neuromuscular Blockade for Post-Cardiac Arrest Care
NCT02260258 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Intravenous Lidocaine on Clinical Outcomes of Patients With ARDS During COVID-19 Pandemia
NCT04609865 ·Status: TERMINATED ·Phase: PHASE3
-
Strong Albumin Solutions in Patients With Septic Shock
NCT05208242 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Bicarbonate in Patients With Out-of-hospital Cardiac Arrest
NCT02303548 ·Status: COMPLETED ·Phase: PHASE2
-
Targeted Perfusion Based Haemodynamic Management in Critically Ill Patients Using Urethral Perfusion
NCT06158555 ·Status: RECRUITING ·Phase: NA
-
Naloxone for Opioid Associated Out of Hospital Cardiac Arrest
NCT06251609 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Low Dose Vasopressin in Traumatic Shock
NCT00420407 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Double Blind Randomized Trial of Saline vs Pentaspan for Resuscitation After Cardiac Surgery
NCT00337805 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Fluid Resuscitation With Hydroxyethyl Starch 130/0.4 in Trauma Patients
NCT03486600 ·Status: UNKNOWN ·Phase: NA
-
Surviving PEA in Roanoke (SPEAR) Study
NCT05283850 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
"Effects of Neuromuscular Blocking Agents on End Expiratory Lung Volume During Moderate-severe ARDS"
NCT04996394 ·Status: COMPLETED
-
Vexus-guided Fluid Management in Patients With Septic Shock After the Resuscitation Phase
NCT06227702 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Restricted or Liberal Fluid for Haemodynamic Resuscitation in Sepsis
NCT05453565 ·Status: NOT_YET_RECRUITING
-
Endothelial Dysfunction in Resuscitated Cardiac Arrest
NCT02685618 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Amount of Fluid for Circulatory Resuscitation on Renal Function in Patients in Shock
NCT02666404 ·Status: TERMINATED ·Phase: NA
-
Impact of Tissue Plasminogen Activator (tPA) Treatment for an Atypical Acute Respiratory Distress Syndrome (COVID-19)
NCT04453371 ·Status: WITHDRAWN ·Phase: PHASE3
-
Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS
NCT04333368 ·Status: COMPLETED ·Phase: PHASE1/PHASE2